Amoéba

📍 CHASSIEU, France🗓 Founded 2010👥 37 employees💰 Last funded Dec 2020
Biotechnology Research🌐 amoeba-nature.com
Website LinkedIn
Founded in 2010, Amoéba is an innovative industrial greentech specialised in the treatment of microbiological risk of natural resources. Our biosolutions are based on a unique micro-organism, the amoeba Willaertia magna C2c Maky. Thanks to our scientific, industrial and commercial know-how, we are able to provide biological alternatives for different applications and industries. 𝙊𝙐𝙍 𝙎𝙊𝙇𝙐𝙏𝙄𝙊𝙉𝙎 💄 Cosmetics : Our latest innovation offers anti-aging and UV protection properties. In October 2023, in vitro studies showed that this lysate stimulates cellular functions, activates wound healing genes, promotes hyaluronic acid synthesis, and enhances anti-infective immunity. These benefits were confirmed in a spring 2024 clinical study, with statistically significant results. Amoéba has successfully registered this ingredient on the INCI list, facilitating its commercialization and establishing it as a key player in innovative skincare solutions. 🌱 Biocontrol "AXPERA": Our second technology enables plant protection in agriculture and is based on the antifungal properties of the amoeba in its lysed (non-living) form. In 2022, the US Environmental Protection Agency (US EPA) has granted approval for the use of our solution in agriculture in the USA. In the same year, Austria issued a positive recommendation for the approval of our active substance in Europe. With this innovation, Amoéba contributes to an efficient, secure and more virtuous biological agriculture. 💧 Biocide "BIOMEBA": This historical application, initiated at the foundation of the company, enables the treatment of water in cooling towers and uses the amoeba Willaertia magna C2c Maky in its living form. In 2022, the US EPA has approved the use of our active substance in closed cooling systems in the USA, making our solution the first biological biocide approved for global industrial water treatment. Youtube 👉 @AmoebaNature X 👉 @AmoebaNature
7
Total investors
2
Early stage
4
Mid stage
1
Late stage
2010
Founded

Investors

7 investors
All
Early stage
Mid stage
Late stage
Investor geography2 countries
France
6
Singapore
1
Investor activity2011–2020 · investors recorded per year
201112012120131201422015120201
Recent (last 2y)Earlier
Frequently asked questions
Who invested in Amoéba?
Amoéba has 7 investors on record on gritt.io, including 2 early-stage backers, 4 mid-stage and 1 late-stage investors.
When did Amoéba last raise funding?
The most recent investment in Amoéba recorded on gritt.io was in December 2020.
When was Amoéba founded?
Amoéba was founded in 2010.
What industry is Amoéba in?
Amoéba operates in Biotechnology Research. Find similar Biotechnology Research investors on gritt.io.
Where is Amoéba based?
Amoéba is headquartered in CHASSIEU, France.